Cardiovascular & Hematological Disorders-Drug Targets

(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders)

Editor-in-Chief:

Garry X. Shen  
University of Manitoba
Winnipeg, MB
Canada

Back



Meet Our Editorial Board Member free to download

Volume:17   Issue:2
Pp: 73-73
Gjumrakch Aliev
DOI: 10.2174/1871529X1702171212122953



Heart Failure with Preserved Ejection Fraction: Entresto a Possible Option

Volume:17   Issue:2
Pp: 80-85
Taylor Bramblett, Mohamed Teleb*, Aymen Albaghdadi, Harsh Agrawal and Debabrata Mukherjee
DOI: 10.2174/1871529X17666170703120237



Cardiovascular Concern of 5-HT2B Receptor and Recent Vistas in the Development of Its Antagonists

Volume:17   Issue:2
Pp: 86-104
Komal Padhariya, Richie Bhandare*, Daniel Canney and Vinay Velingkar
DOI: 10.2174/1871529X17666170703115111



Is Anticoagulation with Novel Oral Anticoagulants an Effective Treatment for Tuberculosis Patients not Achieving a Therapeutic Range with Vitamin K Antagonists? A Systematic Review

Volume:17   Issue:2
Pp: 105-110
Marco Fiore*, Alberto Enrico Maraolo, Paolo Chiodini, Claudio Cerchione, Ivan Gentile, Guglielmo Borgia and Maria Caterina Pace
DOI: 10.2174/1871529X17666170703115545



Congenital FX Deficiency Rio Tercero: A New Heterozygous Missense Mutation (Cys241Gly) with a Potentiating Effect by a Polymorphism (c. 503-57C>T)#

Volume:17   Issue:2
Pp: 136-141
Antonio Girolami*, Salvador Minoldo, Silvia Ferrari, Diego Colussi, Anna Maria Lombardi and Hugo Guglielmone
DOI: 10.2174/1871529X17666170908105839